Cansino Biologics Inc. Posted 1 Billion Yuan Net Loss in 2022

Cansino Biologics Inc. (康希诺生物股份公司) (688185.SH) reported a net loss of 1 billion yuan in 2022, reversing a net profit of 1.9 billion yuan for the previous year.

Meanwhile, the company posted 1 billion yuan in revenue, down 75.9% year-on-year.

At the end of the reporting period, it had 11.5 billion yuan in total assets and 4.2 billion yuan in total liabilities, with a liability-to-asset ratio of 36.8%.